<?xml version="1.0" encoding="UTF-8"?>
<p>The finding of SARS‐CoV‐2 RNA in stool samples by amplification is now accepted widely.
 <xref rid="jmv26066-bib-0134" ref-type="ref">
  <sup>134</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0135" ref-type="ref">
  <sup>135</sup>
 </xref> Early data also suggests that a substantial portion of patients suffer gastrointestinal complaints.
 <xref rid="jmv26066-bib-0021" ref-type="ref">
  <sup>21</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0136" ref-type="ref">
  <sup>136</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0137" ref-type="ref">
  <sup>137</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0138" ref-type="ref">
  <sup>138</sup>
 </xref> Wölfel et al
 <xref rid="jmv26066-bib-0043" ref-type="ref">
  <sup>43</sup>
 </xref> did not find infectious virus in multiple samples. Zang et al
 <xref rid="jmv26066-bib-0139" ref-type="ref">
  <sup>139</sup>
 </xref> also did not find live virus in stool samples. In contrast, others have now independently confirmed that the virus can be cultured from the feces from an active infection.
 <xref rid="jmv26066-bib-0140" ref-type="ref">
  <sup>140</sup>
 </xref>, 
 <xref rid="jmv26066-bib-0141" ref-type="ref">
  <sup>141</sup>
 </xref>
</p>
